UK markets open in 39 minutes

Beam Therapeutics Inc. (BEAM)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
90.60-1.40 (-1.52%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close92.00
Open92.86
Bid0.00 x 1200
Ask0.00 x 3000
Day's range89.62 - 92.86
52-week range18.83 - 138.52
Volume497,447
Avg. volume877,103
Market cap5.932B
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-6.76
Earnings date10 Aug 2021 - 16 Aug 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est109.83
  • 3 Healthcare Stocks That Could Make You Rich
    Motley Fool

    3 Healthcare Stocks That Could Make You Rich

    If you're looking to take that same path, healthcare stands out as one of the biggest market opportunities around. Here are three healthcare stocks that could make you rich over the next decade. Beam Therapeutics (NASDAQ: BEAM) is the pioneering leader in genomic base editing.

  • Why CRISPR Therapeutics, Editas Medicine, and Beam Therapeutics Dropped This Week
    Motley Fool

    Why CRISPR Therapeutics, Editas Medicine, and Beam Therapeutics Dropped This Week

    After rallying on the coattails of Intelllia's breakthrough, these companies have given back their June gains.

  • Why Beam Therapeutics Climbed 64.5% in June
    Motley Fool

    Why Beam Therapeutics Climbed 64.5% in June

    Shares of Beam Therapeutics (NASDAQ: BEAM) jumped almost 65% last month according to S&P Global Market Intelligence. The move was in concert with other gene editing companies after Intellia Therapeutics and Regeneron announced results from a phase 1 study. The data indicated the pair had successfully used CRISPR-Cas9 to treat a rare liver disease.